Symbols

CAMP

CAMP4 Therapeutics·NASDAQ

--(--)

CAMP fundamentals

CAMP Q2 2025 Earnings

CAMP4 Therapeutics (CAMP) released its earnings on Aug 14, 2025: revenue was 1.50M (YoY --), beat estimates; EPS was -0.62 (YoY +98.82%), beat estimates.

Revenue / YoY

1.50M

EPS / YoY

-0.62

+98.82%

Report date

Aug 14, 2025

Earnings

EPS

Revenue

Revenue & Expenses

CAMP has released its 2025 Q4 earnings report, with revenue of 348.00K, reflecting a YoY change of -46.63%, and net profit of -40.28M, showing a YoY change of -203.37%. The Sankey diagram below clearly presents CAMP's revenue sources and cost distribution.

Key Indicators

CAMP4 Therapeutics (CAMP) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

CAMP4 Therapeutics (CAMP)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

CAMP4 Therapeutics (CAMP)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

CAMP4 Therapeutics (CAMP)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown